Frequent antenatal screening dramatically reduces maternal mortality on Thai-Myanmar border

July 18, 2012

Frequent antenatal screening has allowed doctors to detect and treat malaria in its early stages on the border of Thailand and Myanmar, dramatically reducing the number of deaths amongst pregnant women.

In an analysis of 25 years' worth of data, in 50,981 women, from antenatal clinics at the Shoklo Malaria Research Unit, researchers found that the number of deaths from Plasmodium falciparum malaria fell from an estimated 1,000 deaths per 100,000 pregnant women before the introduction of screening to zero in 2005.

The Shoklo Malaria Research Unit is part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme, based in the refugee camps on the border of Thailand and Myanmar. It is situated in a region where malaria is endemic.

Researchers at the Unit studied all medical records from women attending its antenatal clinics from May 1986 to the end of 2010 to assess levels of maternal mortality. A significant disparity exists in maternal mortality between women living in the least developed countries and those living in industrialised countries: a study in 2005 estimated that the average lifetime risk of dying from complications related to pregnancy or childbirth was 300 times higher in the least developed countries. Even less well documented is maternal death in amongst high risk groups such as migrants and refugees.

In findings published today in the journal PLoS ONE, researchers at Shoklo found a six-fold decline in maternal mortality from 499 in the period 1986-1990 to 79 in the period 2006-10 amongst refugees. A significant proportion of this reduction in deaths was due to the early detection and treatment of malaria.

Dr Rose McGready from the Shoklo Malaria Research Unit says: "We have seen a massive reduction in malaria-related maternal mortality. This gives us hope and shows that deaths from malaria are preventable. Even though treatment options for pregnant women infected with malaria are limited, frequent antenatal screening clearly works and as such, we believe it should play a larger role in tackling the disease. However, there are still significant rates of maternal death in the more mobile migrant populations and this is something that needs to be addressed."

Alongside malaria-related deaths, the most common causes of death amongst pregnant women were haemorrhage and sepsis (infection of the blood).

"Clearly haemorrhage and sepsis need to be tackled as overall mortality remains high, despite advances against malaria," adds Dr McGready. "Delivery with trained midwives rather than at home is likely to have a significant impact, but access remains a problem for migrant women. More outreach to these women during or before their pregnancy will be needed."
-end-


Wellcome Trust

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.